🇺🇸 Adreview in United States

FDA authorised Adreview on 19 September 2008

Marketing authorisation

FDA — authorised 19 September 2008

  • Marketing authorisation holder: GE HEALTHCARE
  • Status: approved

Adreview in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Adreview approved in United States?

Yes. FDA authorised it on 19 September 2008.

Who is the marketing authorisation holder for Adreview in United States?

GE HEALTHCARE holds the US marketing authorisation.